AVEO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: AVEO Shares Outstanding History and AVEO YTD Return |
AVEO Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Also see: AVEO Shares Outstanding History and AVEO YTD Return |
AVEO Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
+5.29% CAGR Mouse over chart for data details
|
AVEO Stock Price Chart |
About AVEO Pharmaceuticals Inc |
AVEO Pharmaceuticals is a commercial stage, oncology-focused biopharmaceutical company committed to delivering medicines for patients with cancer. Co.'s product candidates include: Tivozanib, which is for the treatment of renal cell carcinoma, hepatocellular carcinoma, immunologically cold tumors and cholangiocarcinoma; Ficlatuzumab, which is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that targets hepatocyte growth factor; AV-380, which is a humanized IgG1 monoclonal antibody that targets growth differentiation factor 15; AV-203, which is a humanized IgG1 monoclonal antibody that targets ErbB3; and AV-353, which is a IgG1 monoclonal antibody that targets the Notch 3 pathway. We show 51 historical shares outstanding datapoints in our AVEO shares outstanding history coverage, used to compute AVEO market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AVEO market cap history over the course of time is important for investors interested in comparing AVEO's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AVEO versus a peer is one thing; comparing AVEO market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AVEO can fluctuate over the course of history. With this page we aim to empower investors researching AVEO by allowing them to research the AVEO market cap history. |
AVEO Current Stock Quote |
Free AVEO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: The Importance of Market Cap | |
|
AVEO Share Performance |
Market Cap Peers |
AVEO Pharmaceuticals (AVEO) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AVGR Market Cap History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.